GOLDMAN SACHS GROUP INC - VERRICA PHARMACEUTICALS INC ownership

VERRICA PHARMACEUTICALS INC's ticker is VRCA and the CUSIP is 92511W108. A total of 68 filers reported holding VERRICA PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 8.42 and the average weighting 0.0%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of VERRICA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$53,834
-56.8%
13,857
-35.8%
0.00%
Q2 2023$124,603
-72.7%
21,595
-69.2%
0.00%
Q1 2023$456,073
+794.3%
70,165
+298.8%
0.00%
Q3 2022$51,000
-16.4%
17,594
-44.6%
0.00%
Q2 2022$61,000
-30.7%
31,750
+193.9%
0.00%
Q1 2022$88,000
-83.4%
10,802
-67.7%
0.00%
Q4 2019$531,000
+42.4%
33,393
+32.2%
0.00%
Q3 2019$373,000
-62.7%
25,254
-50.2%
0.00%
Q2 2018$1,001,00050,7140.00%
Other shareholders
VERRICA PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Perceptive Advisors 5,038,983$19,576,4480.65%
BML Capital Management, LLC 150,000$582,7500.54%
Caligan Partners LP 259,593$1,009,8170.46%
Avoro Capital Advisors LLC 2,954,064$11,476,5390.18%
Boxer Capital, LLC 166,955$648,6200.04%
SteelPeak Wealth, LLC 136,986$532,1910.03%
Legacy Trust 18,750$72,8440.02%
Miracle Mile Advisors, LLC 118,221$459,2890.01%
SPC Financial, Inc. 30,000$116,5500.01%
KORNITZER CAPITAL MANAGEMENT INC /KS 99,251$385,5900.01%
View complete list of VERRICA PHARMACEUTICALS INC shareholders